Clinical Trial Update: Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating docetaxel plus a phytochemical for hormone-independent metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Phytochemical
• Taxotere (docetaxel)

Snippet

Sponsor: Centre Jean Perrin | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: COMPLETED